HomeEXECUTIVESCorWave Appoints Magalie Durrèche as Chief Financial Officer

CorWave Appoints Magalie Durrèche as Chief Financial Officer

CorWave, a French company developing and manufacturing innovative cardiac assist devices, announces the appointment of Magalie Durrèche as Chief Financial Officer. Magalie Durrèche has over twenty years of experience in corporate finance, mainly in the industrial sector, which will be a major asset for the development of CorWave.

Before joining CorWave, Magalie Durrèche served as the Chief Financial Officer, Aftersales & Circular Economy, for the entire Stellantis group, an automotive company with a net revenue of €179.6 billion (2022) and industrial operations in more than 30 countries. After graduating from Neoma Business School, she began her career in financial auditing at PwC before joining the Financial Consolidation teams at Sodexo. She later joined the automotive manufacturer PSA, where she held various positions within the financial department between 2008 and 2015, providing her with a 360-degree view of the group’s various activities (Research and Development, Production and Industrial Partnerships, Sales, Financing, etc.). In 2015, she was appointed Head of Investor Relations and took part in the rollout of PSA Group’s profitable growth plan “Push to Pass” to financial markets. She was promoted in 2017 to Chief Financial Officer of PSA Bank (now Stellantis Financial Services), a group operating in 14 countries and generating over €1.5 billion in net banking income. In early 2020, she became Director of Consolidation and Financial Reporting and joined the project team for the merger between PSA and FCA (Fiat Chrysler Automobiles). She thus actively contributed to the formation of the New York Stock Exchange (NYSE)-listed Stellantis Group.

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

Magalie Durrèche, Chief Financial Officer of CorWave, states: “I am very pleased to join CorWave and to participate in its transformation into an industrial company in the clinical phase and then in the commercial phase. CorWave is at a pivotal time, having recently completed a second closing of its Series C and preparing to inaugurate its industrial site.”

“I am thrilled to welcome Magalie as Chief Financial Officer” comments Louis de Lillers, Chief Executive Officer of CorWave. “She brings solid experience, having held very high responsibilities within Stellantis, an industrial group of international scale. Endowed with a deep entrepreneurial mindset, Magalie will contribute to transforming CorWave into a global leader in cardiac assist devices. Her knowledge of the European and American financial markets, along with her experience with ESG (Environmental, Social, and Governance) matters, will be valuable assets for our upcoming growth phases. I would also like to warmly thank Zina Hamoumi who has greatly contributed to the development of CorWave in recent years.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Dr Charles R Gordon was the founding Chairman of the Board for Baylor Scott & White's Texas Spine & Joint Hospital. Over the years the hospital has grown, and majority interest of the hospital was sold to Baylor Scott & White and United Surgical Partners International (USPI).
"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.

By using this website you agree to accept Medical Device News Magazine Privacy Policy